Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1995;25:928-934

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Campbell, D. J.
Right arrow Articles by Harrap, S. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Campbell, D. J.
Right arrow Articles by Harrap, S. B.

(Hypertension. 1995;25:928-934.)
© 1995 American Heart Association, Inc.


Articles

Angiotensin Peptides in Spontaneously Hypertensive and Normotensive Donryu Rats

Duncan J. Campbell; Ann-Maree Duncan; Athena Kladis; Stephen B. Harrap

From St Vincent's Institute of Medical Research, Fitzroy; and the Department of Medicine, Austin Hospital, Heidelberg, (S.B.H.), Victoria, Australia.

Correspondence to Dr D.J. Campbell, St Vincent's Institute of Medical Research, 41 Victoria Parade, Fitzroy, Victoria 3065, Australia.

Abstract The renin-angiotensin system has been implicated in the pathogenesis of hypertension in spontaneously hypertensive rats (SHR). Given that SHR may have normal or suppressed plasma levels of renin and angiotensin peptides, we examined whether the tissue levels of angiotensin peptides are elevated in these rats. We measured angiotensin-(1-7) [Ang-(1-7)], Ang II, and Ang I in plasma, kidney, adrenal, heart, aorta, brown adipose tissue, lung, and brain of male SHR and normotensive Donryu rats at 6, 10, and 20 weeks of age. SHR had higher blood pressures and ratios of heart weight to body weight at all ages. Plasma renin levels of SHR were 13% to 32% of the levels of Donryu rats. Although plasma angiotensin-converting enzyme activity was lower in SHR than in Donryu rats, lung was the only SHR tissue with a reduced Ang II–Ang I ratio. Ang II levels in SHR adrenal were 24% to 42% of the levels of Donryu adrenal, and for SHR plasma, aorta, brown adipose tissue, and lung, Ang II levels were 38% to 93% of the levels of Donryu rats. For kidney and heart, Ang II levels were similar in SHR and Donryu rats at 6 weeks of age although suppressed in SHR at 10 and 20 weeks. Moreover, brain Ang II levels were higher in SHR than Donryu rats at 6 weeks of age and similar at 10 and 20 weeks of age. Our finding that all SHR tissues, except for brain at 6 weeks of age, showed Ang II levels similar to or less than the levels of Donryu rats indicates that, apart from a possible role for brain of young rats, the hypertension of SHR is not due to increased Ang II levels.


Key Words: angiotensins • rats, inbred SHR • rats, inbred strains • renin • angiotensinogen • angiotensin-converting enzyme • aldosterone




This article has been cited by other articles:


Home page
Exp PhysiolHome page
A. G. Filho, A. J. Ferreira, S. H. S. Santos, S. R. S. Neves, E. R. Silva Camargos, L. K. Becker, H. A. Belchior, M. F. Dias-Peixoto, S. V. B. Pinheiro, and R. A. S. Santos
Selective increase of angiotensin(1-7) and its receptor in hearts of spontaneously hypertensive rats subjected to physical training
Exp Physiol, May 1, 2008; 93(5): 589 - 598.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
A. Advani, D. J. Kelly, S. L. Advani, A. J. Cox, K. Thai, Y. Zhang, K. E. White, R. M. Gow, S. M. Marshall, B. M. Steer, et al.
Role of VEGF in maintaining renal structure and function under normotensive and hypertensive conditions
PNAS, September 4, 2007; 104(36): 14448 - 14453.
[Abstract] [Full Text] [PDF]


Home page
J DAIRY SCIHome page
A. Geerlings, I. C. Villar, F. H. Zarco, M. Sanchez, R. Vera, A. Z. Gomez, J. Boza, and J. Duarte
Identification and characterization of novel Angiotensin-converting enzyme inhibitors obtained from goat milk.
J Dairy Sci, September 1, 2006; 89(9): 3326 - 3335.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
S. Welsch, E. Schordan, C. Coquard, T. Massfelder, N. Fiaschi-Taesch, J.-J. Helwig, and M. Barthelmebs
Abnormal Renovascular Parathyroid Hormone-1 Receptor in Hypertension: Primary Defect or Secondary to Angiotensin II Type 1 Receptor Activation?
Endocrinology, September 1, 2006; 147(9): 4384 - 4391.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
J. H. Dubinion, Z. Mi, and E. K. Jackson
Role of Renal Sympathetic Nerves in Regulating Renovascular Responses to Angiotensin II in Spontaneously Hypertensive Rats
J. Pharmacol. Exp. Ther., June 1, 2006; 317(3): 1330 - 1336.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
J. H. Dubinion, Z. Mi, C. Zhu, L. Gao, and E. K. Jackson
Pancreatic Polypeptide-Fold Peptide Receptors and Angiotensin II-Induced Renal Vasoconstriction
Hypertension, March 1, 2006; 47(3): 545 - 551.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
U. C. Kopp and M. Z. Cicha
Impaired substance P release from renal sensory nerves in SHR involves a pertussis toxin-sensitive mechanism
Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2004; 286(2): R326 - R333.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
L. Gao, C. Zhu, and E. K. Jackson
alpha 2-Adrenoceptors Potentiate Angiotensin II- and Vasopressin-Induced Renal Vasoconstriction in Spontaneously Hypertensive Rats
J. Pharmacol. Exp. Ther., May 1, 2003; 305(2): 581 - 586.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
H. Mitani, N. Ishizaka, T. Aizawa, M. Ohno, S.-i. Usui, T. Suzuki, T. Amaki, I. Mori, Y. Nakamura, M. Sato, et al.
In Vivo klotho Gene Transfer Ameliorates Angiotensin II-Induced Renal Damage
Hypertension, April 1, 2002; 39(4): 838 - 843.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
E. K. Jackson, W. A. Herzer, C. K. Kost Jr, and S. J. Vyas
Enhanced Interaction Between Renovascular {alpha}2-Adrenoceptors and Angiotensin II Receptors in Genetic Hypertension
Hypertension, September 1, 2001; 38(3): 353 - 360.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
R. D. P. Machado, R. A. S. Santos, and S. P. Andrade
Mechanisms of angiotensin-(1-7)-induced inhibition of angiogenesis
Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2001; 280(4): R994 - R1000.
[Abstract] [Full Text] [PDF]


Home page
Journal of Renin-Angiotensin-Aldosterone SystemHome page
A. M Allen
Blockade of angiotensin AT1-receptors in the rostral ventrolateral medulla of spontaneously hypertensive rats reduces blood pressure and sympathetic nerve discharge
Journal of Renin-Angiotensin-Aldosterone System, March 1, 2001; 2(1_suppl): S120 - S124.
[Abstract] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
H.-C. Chen, J. L. Bouchie, A. S. Perez, A. C. Clermont, S. Izumo, J. Hampe, and E. P. Feener
Role of the Angiotensin AT1 Receptor in Rat Aortic and Cardiac PAI-1 Gene Expression
Arterioscler Thromb Vasc Biol, October 1, 2000; 20(10): 2297 - 2302.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
E. K. Jackson, W. A. Herzer, Z. Mi, S. J. Vyas, and C. K. Kost Jr
Low-Dose Angiotensin II Reduces Urinary Cyclic AMP Excretion in Spontaneously Hypertensive, But Not Normotensive, Rats: Independence from Hypertension and Renal Hemodynamic Effects of Angiotensin
J. Pharmacol. Exp. Ther., October 1, 1999; 291(1): 115 - 123.
[Abstract] [Full Text]


Home page
J. Pharmacol. Exp. Ther.Home page
E. K. Jackson, W. A. Herzer, S. J. Vyas, and C. K. Kost Jr
Angiotensin II-Induced Renal Vasoconstriction in Genetic Hypertension
J. Pharmacol. Exp. Ther., October 1, 1999; 291(1): 329 - 334.
[Abstract] [Full Text]


Home page
HypertensionHome page
D. P. Healy and L. Song
Kidney Aminopeptidase A and Hypertension, Part I : Spontaneously Hypertensive Rats
Hypertension, February 1, 1999; 33(2): 740 - 745.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
S. N. Iyer, M. C. Chappell, D. B. Averill, D. I. Diz, and C. M. Ferrario
Vasodepressor Actions of Angiotensin-(1–7) Unmasked During Combined Treatment With Lisinopril and Losartan
Hypertension, February 1, 1998; 31(2): 699 - 705.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
H. A.J. Struijker-Boudier, H. van Essen, G. Fazzi, J. G.R. De Mey, H. Y. Qiu, and B. I. Levy
Disproportional Arterial Hypertrophy in Hypertensive mRen-2 Transgenic Rats
Hypertension, November 1, 1996; 28(5): 779 - 784.
[Abstract] [Full Text]


Home page
HypertensionHome page
S. B. Harrap and J. B. O'Sullivan
Cardiac Transplantation, Perindopril, and Left Ventricular Hypertrophy in Spontaneously Hypertensive Rats
Hypertension, October 1, 1996; 28(4): 622 - 626.
[Abstract] [Full Text]


Home page
HypertensionHome page
K. Tamura, S. Umemura, N. Nyui, T. Yamakawa, S. Yamaguchi, T. Ishigami, S.-i. Tanaka, K. Tanimoto, N. Takagi, H. Sekihara, et al.
Tissue-Specific Regulation of Angiotensinogen Gene Expression in Spontaneously Hypertensive Rats
Hypertension, June 1, 1996; 27(6): 1216 - 1223.
[Abstract] [Full Text]